Raleigh Capital Management Inc. Sells 379 Shares of UnitedHealth Group Incorporated $UNH

Raleigh Capital Management Inc. cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,241 shares of the healthcare conglomerate’s stock after selling 379 shares during the quarter. Raleigh Capital Management Inc.’s holdings in UnitedHealth Group were worth $387,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Bayforest Capital Ltd raised its position in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its holdings in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares during the last quarter. IAG Wealth Partners LLC bought a new position in shares of UnitedHealth Group during the first quarter valued at $42,000. Kentucky Trust Co grew its stake in shares of UnitedHealth Group by 53.8% in the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock worth $45,000 after purchasing an additional 50 shares during the last quarter. Finally, O Brien Wealth Partners LLC raised its position in shares of UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after acquiring an additional 37 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.0%

NYSE:UNH opened at $345.11 on Wednesday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a market cap of $312.56 billion, a PE ratio of 14.95, a PEG ratio of 2.25 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a 50-day moving average of $303.65 and a 200-day moving average of $357.64.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the prior year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on UNH. KeyCorp dropped their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Truist Financial increased their price target on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a report on Tuesday, September 9th. Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Wells Fargo & Company lowered their target price on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a report on Monday, August 4th. Finally, Piper Sandler cut their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.